587874-97-3

Upstream product

• 124243-65-8 N-<2-(2-hydroxyethoxy)ethyl>benzamide 
• 124-63-0 methanesulfonyl chloride 
• 93-97-0 benzoic acid anhydride 

Downstream Products

• 587875-01-2 C₂₄H₃₃N₃O₅ 
• 587874-98-4 2-{bis-[2-(2-benzylamino-ethoxy)-ethyl]-amino}-ethanol 
• 587874-99-5 2-(10,16-dibenzyl-1,7,13-trioxa-4,10,16-triaza-cyclooctadec-4-yl)-ethanol 
• 587875-00-1 diisopropyl-phosphoramidous acid 2-cyano-ethyl ester 2-(10,16-dibenzyl-1,7,13-trioxa-4,10,16-triaza-cyclooctadec-4-yl)-ethyl ester 
• 923578-78-3 3-{bis-[2-(2-benzoylamino-ethoxy)-ethyl]-amino}-propan-1-ol 

Relevant academic research and scientific papers

Synthesis of an asymmetrically substituted AZA crown ether as metal and amino acid binding site in DNA conjugates

Crown ether 4 as a receptor core for protonated primary amines such as amino acids has been synthesized and incorporated into oligodeoxynucleotides as dangling ends.

MRI sensing of neurotransmitters with a crown ether appended Gd3+ complex

Molecular magnetic resonance imaging (MRI) approaches that detect biomarkers associated with neural activity would allow more direct observation of brain function than current functional MRI based on blood-oxygen-level-dependent contrast. Our objective wa

DNA CONTROLLED ASSEMBLY OF LIPID MEMBRANES

The present invention relates to detection of target nucleic acids by target nucleic acid induced liposome assembly. The invention provides oligonucleotides for use in detection and a method of detecting target nucleic acids. Other aspects of the invention are use of the oligonucleotide of the invention for detection, a kit for detection, a method of treatment comprising administrating the oligonucleotide of the invention and a pharmaceutical composition comprising the oligonucleotide of the invention.

DNA CONTROLLED ASSEMBLY OF LIPID MEMBRANES

The present invention relates to detection of target nucleic acids by targetnucleic acid induced liposome assembly. The invention provides oligonucleotides for use in detection and a method of detecting target nucleic acids.Other aspects of the invention

Toward a catalytic site in DNA: Polyaza crown ether as non-nucleosidic building blocks in DNA conjugates

A number of functionalized polyaza crown ether building blocks have been incorporated into DNA-conjugates as catalytic Cu2+ binding sites. The effect of the DNA-conjugate catalyst on the stereochemical outcome of a Cu2+-catalyzed Diels-Alder reaction will

A substituted triaza crown ether as a binding site in DNA conjugates

Synthesis of an asymmetrically substituted triaza crown ether, its incorporation into the 3′-end and 5′-end of nine-mer oligonucleotides, and the influence of various alkanediamine ligands on duplex thermostabilities are reported.